{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T18:14:14Z","timestamp":1770142454453,"version":"3.49.0"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      N6-methyladenosine (m\n                      <jats:sup>6<\/jats:sup>\n                      A) is a dynamic mRNA modification influencing transcript fate and cellular identity, especially in cancer. While oncogenic roles of m\n                      <jats:sup>6<\/jats:sup>\n                      A regulators in AML cells are known, their impact on the leukemic immune microenvironment is unclear.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this study, we constructed a single-cell atlas of macrophages in AML by integrating publicly available scRNA-seq datasets from 129 patient cohorts. Data were batch-corrected using Seurat and Harmony. Macrophage subpopulations were identified, and the expression and activity of 29 m\n                      <jats:sup>6<\/jats:sup>\n                      A regulators were analyzed. Pseudotime analysis (Monocle3), cell\u2013cell communication (CellChat), and pathway enrichment (Metascape) analyses were performed to explore m\n                      <jats:sup>6<\/jats:sup>\n                      A-related functional programs. Survival analysis was conducted using Kaplan\u2013Meier curves. RT-qPCR was used to verify the correlation between m\n                      <jats:sup>6<\/jats:sup>\n                      A regulatory molecules and prognosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Our findings indicated that m\n                      <jats:sup>6<\/jats:sup>\n                      A regulators are associated with macrophage fate. Writer-high macrophages showed enhanced proliferation and differentiation, maintaining monocyte-like features. Eraser-high macrophages remodeled macrophage function toward an M1-like, pro-inflammatory and antigen-presenting state. Reader-high macrophages drove macrophages toward an immunosuppressive, M2-like phenotype, while m\n                      <jats:sup>6<\/jats:sup>\n                      A-deficient cells exhibit features of functional exhaustion. Survival analysis based on bulk RNA-seq data further revealed that m\n                      <jats:sup>6<\/jats:sup>\n                      A-regulated macrophage profiles were associated with distinct prognostic stratification in AML patients. RT-qPCR analysis of macrophages isolated from clinical AML samples further validated these findings, showing that patients with favorable prognosis exhibited significantly higher expression levels of erasers compared to those with poor prognosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      These results highlight m\n                      <jats:sup>6<\/jats:sup>\n                      A system\u2019s role in macrophage reprogramming and suggest that targeting m\n                      <jats:sup>6<\/jats:sup>\n                      A regulators in macrophages may serve as a potential basis for prognostic stratification and a promising therapeutic strategy in AML.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1739959","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T06:30:05Z","timestamp":1770100205000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["m6A demethylase\u2013driven reprogramming of leukemia-associated macrophages predicts improved outcomes in acute myeloid leukemia"],"prefix":"10.3389","volume":"17","author":[{"given":"Zhiyu","family":"Shi","sequence":"first","affiliation":[{"name":"Innovation Research Institute of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Hematology, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University","place":["Jinan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Innovation Research Institute of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Peng","sequence":"additional","affiliation":[{"name":"Innovation Research Institute of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"An","sequence":"additional","affiliation":[{"name":"School of Rehabilitation Medicine, Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingjun","family":"Zhu","sequence":"additional","affiliation":[{"name":"Innovation Research Institute of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]},{"name":"Key Laboratory of Traditional Chinese Medicine Classical Theory, Ministry of Education, Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[{"name":"Innovation Research Institute of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]},{"name":"Department of Hematology, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University","place":["Jinan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(23)00108-3","article-title":"Acute myeloid leukaemia","volume":"401","author":"DiNardo","year":"2023","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4416","article-title":"The N(6)-methyladenosine (m(6)A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells","volume":"23","author":"Vu","year":"2017","journal-title":"Nat Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.11.017","article-title":"FTO plays an oncogenic role in acute myeloid leukemia as a N(6)-methyladenosine RNA demethylase","volume":"31","author":"Li","year":"2017","journal-title":"Cancer Cell"},{"key":"B4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.stem.2019.03.021","article-title":"Targeting the RNA m(6)A reader YTHDF2 selectively compromises cancer stem cells in acute myeloid leukemia","volume":"25","author":"Paris","year":"2019","journal-title":"Cell Stem Cell"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-480129","article-title":"Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment","volume":"122","author":"Mussai","year":"2013","journal-title":"Blood."},{"key":"B6","doi-asserted-by":"publisher","first-page":"123297","DOI":"10.1016\/j.lfs.2024.123297","article-title":"M2 macrophages secrete CCL20 to regulate iron metabolism and promote daunorubicin resistance in AML cells","volume":"361","author":"Chen","year":"2025","journal-title":"Life Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1683347","DOI":"10.1080\/2162402X.2019.1683347","article-title":"The M2 macrophage marker CD206: a novel prognostic indicator for acute myeloid leukemia","volume":"9","author":"Xu","year":"2020","journal-title":"Oncoimmunology."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00212.2019","article-title":"The N(6)-methyladenosine (m(6)A)-forming enzyme METTL3 facilitates M1 macrophage polarization through the methylation of STAT1 mRNA","volume":"317","author":"Liu","year":"2019","journal-title":"Am J Physiol Cell Physiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12931-024-03061-0","article-title":"YTHDF1-mediated m6A modification of GBP4 promotes M1 macrophage polarization in acute lung injury","volume":"26","author":"Cao","year":"2025","journal-title":"Respir Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2100209","DOI":"10.1016\/j.bbrc.2025.152417","article-title":"The m6A reader IGF2BP2 regulates macrophage phenotypic activation and inflammatory diseases by stabilizing TSC1 and PPARgamma","volume":"8","author":"Wang","year":"2021","journal-title":"Adv Sci (Weinh)."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3153362","DOI":"10.1155\/2022\/3153362","article-title":"YTHDF2 Regulates Macrophage Polarization through NF-kappaB and MAPK Signaling Pathway Inhibition or p53 Degradation","volume":"2022","author":"Cai","year":"2022","journal-title":"Dis Markers."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.424","article-title":"Histone demethylase JMJD1C promotes the polarization of M1 macrophages to prevent glioma by upregulating miR-302a","volume":"11","author":"Zhong","year":"2021","journal-title":"Clin Transl Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.125.322508","article-title":"ALKBH5 regulates macrophage senescence and accelerates atherosclerosis by promoting CCL5 m(6)A modification","volume":"45","author":"Gao","year":"2025","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"111812","DOI":"10.1016\/j.isci.2025.111812","article-title":"The m6A reader HNRNPC is a key regulator in DSS-induced colitis by modulating macrophage phenotype","volume":"28","author":"Fang","year":"2025","journal-title":"iScience."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19082345","article-title":"N6-methyladenosine role in acute myeloid leukaemia","volume":"19","author":"Ianniello","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3410\/f.726713262.793529794","article-title":"m(6)A RNA methylation promotes XIST-mediated transcriptional repression","volume":"537","author":"Patil","year":"2016","journal-title":"Nature."},{"key":"B17","doi-asserted-by":"publisher","first-page":"101181","DOI":"10.1016\/j.gendis.2023.101181","article-title":"Cap-specific terminal N6-methyladeonsine methylation of RNA mediated by PCIF1 and possible therapeutic implications","volume":"12","author":"Zeng","year":"2025","journal-title":"Genes Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41589-018-0184-3","article-title":"N(6-)Methyladenosine methyltransferase ZCCHC4 mediates ribosomal RNA methylation","volume":"15","author":"Ma","year":"2019","journal-title":"Nat Chem Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"42271","DOI":"10.1038\/srep42271","article-title":"AlkB homolog 3-mediated tRNA demethylation promotes protein synthesis in cancer cells","volume":"7","author":"Ueda","year":"2017","journal-title":"Sci Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1016\/j.molcel.2023.05.010","article-title":"RBM33 is a unique m(6)A RNA-binding protein that regulates ALKBH5 demethylase activity and substrate selectivity","volume":"83","author":"Yu","year":"2023","journal-title":"Mol Cell"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-05045-x","article-title":"Establishment of a prognostic model based on m(6)A regulatory factors and stemness of hepatocellular carcinoma using RNA-seq data and scRNA-seq data","volume":"149","author":"Liang","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s12859-018-2435-4","article-title":"Single sample scoring of molecular phenotypes","volume":"19","author":"Foroutan","year":"2018","journal-title":"BMC Bioinf"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-24-0342","article-title":"Single-cell transcriptional atlas of human hematopoiesis reveals genetic and hierarchy-based determinants of aberrant AML differentiation","volume":"6","author":"Zeng","year":"2025","journal-title":"Blood Cancer Discov"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/gpbjnl\/qzaf005","article-title":"Resolving leukemia heterogeneity and lineage aberrations with hematoMap","volume":"23","author":"Dai","year":"2025","journal-title":"Genomics Proteomics Bioinf"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","article-title":"Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity","volume":"176","author":"van Galen","year":"2019","journal-title":"Cell."},{"key":"B26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13059-023-03031-7","article-title":"Single-cell transcriptomics reveals multiple chemoresistant properties in leukemic stem and progenitor cells in pediatric AML","volume":"24","author":"Zhang","year":"2023","journal-title":"Genome Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022017046","article-title":"C1Q labels a highly aggressive macrophage-like leukemia population indicating extramedullary infiltration and relapse","volume":"141","author":"Yang","year":"2023","journal-title":"Blood."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1101\/2023.03.29.23287896","article-title":"Mapping AML heterogeneity - multi-cohort transcriptomic analysis identifies novel clusters and divergent ex-vivo drug responses","volume":"38","author":"Severens","year":"2024","journal-title":"Leukemia."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1268090","article-title":"Construction of an acute myeloid leukemia prognostic model based on m6A-related efferocytosis-related genes","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1177\/10815589251334964","article-title":"Pediatric AML prognostication with an m6A-focused LASSO model","volume":"73","author":"Zhang","year":"2025","journal-title":"J Investig Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-0683-z","article-title":"The m(6)A methyltransferase METTL3 promotes bladder cancer progression via AFF4\/NF-kappaB\/MYC signaling network","volume":"38","author":"Cheng","year":"2019","journal-title":"Oncogene."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-31963","article-title":"METTL3-mediated m(6)A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance","volume":"69","author":"Wang","year":"2020","journal-title":"Gut."},{"key":"B33","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s41419-023-06287-w","article-title":"METTL3 promotes colorectal cancer progression through activating JAK1\/STAT3 signaling pathway","volume":"14","author":"Sun","year":"2023","journal-title":"Cell Death Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3892\/or.2020.7515","article-title":"METTL14 promotes the migration and invasion of breast cancer cells by modulating N6\u2212methyladenosine and hsa\u2212miR\u2212146a\u22125p expression","volume":"43","author":"Yi","year":"2020","journal-title":"Oncol Rep"},{"key":"B35","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41419-020-02847-6","article-title":"WTAP promotes osteosarcoma tumorigenesis by repressing HMBOX1 expression in an m(6)A-dependent manner","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ccell.2020.04.017","article-title":"Targeting FTO suppresses cancer stem cell maintenance and immune evasion","volume":"38","author":"Su","year":"2020","journal-title":"Cancer Cell"},{"key":"B37","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12935-019-1045-1","article-title":"The m(6)A eraser FTO facilitates proliferation and migration of human cervical cancer cells","volume":"19","author":"Zou","year":"2019","journal-title":"Cancer Cell Int"},{"key":"B38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13046-024-03032-9","article-title":"Targeting FTO induces colorectal cancer ferroptotic cell death by decreasing SLC7A11\/GPX4 expression","volume":"43","author":"Qiao","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.04.032","article-title":"ALKBH5 drives immune suppression via targeting AXIN2 to promote colorectal cancer and is a target for boosting immunotherapy","volume":"165","author":"Zhai","year":"2023","journal-title":"Gastroenterology."},{"key":"B40","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41419-022-04672-5","article-title":"YTHDF1 promotes breast cancer cell growth, DNA damage repair and chemoresistance","volume":"13","author":"Sun","year":"2022","journal-title":"Cell Death Dis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa048","article-title":"The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation","volume":"48","author":"Liu","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-2485","article-title":"The m6A reader YTHDF2 promotes bladder cancer progression by suppressing RIG-I-mediated immune response","volume":"83","author":"Zhang","year":"2023","journal-title":"Cancer Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41392-023-01316-8","article-title":"O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N(6)-methyladenosine-dependent manner","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B44","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.ccell.2020.10.004","article-title":"YTHDF3 induces the translation of m(6)A-enriched gene transcripts to promote breast cancer brain metastasis","volume":"38","author":"Chang","year":"2020","journal-title":"Cancer Cell"},{"key":"B45","doi-asserted-by":"publisher","first-page":"109902","DOI":"10.1016\/j.isci.2024.109902","article-title":"YTHDF2 favors protumoral macrophage polarization and implies poor survival outcomes in triple negative breast cancer","volume":"27","author":"Jin","year":"2024","journal-title":"iScience."},{"key":"B46","doi-asserted-by":"publisher","first-page":"111887","DOI":"10.1016\/j.cellsig.2025.111887","article-title":"CALB2 facilitates macrophage M2 polarization to promote the growth and metastasis of pancreatic adenocarcinoma","volume":"134","author":"Hu","year":"2025","journal-title":"Cell Signal"},{"key":"B47","doi-asserted-by":"publisher","first-page":"113037","DOI":"10.1016\/j.intimp.2024.113037","article-title":"Macrophage crosstalk and therapies: Between tumor cells and immune cells","volume":"141","author":"Fan","year":"2024","journal-title":"Int Immunopharmacol."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2017.04.007","article-title":"Cancer cell and macrophage cross-talk in the tumor microenvironment","volume":"35","author":"Dehne","year":"2017","journal-title":"Curr Opin Pharmacol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1186\/s12967-022-03675-2","article-title":"Single-cell transcriptomics reveals the role of Macrophage-Naive CD4 + T cell interaction in the immunosuppressive microenvironment of primary liver carcinoma","volume":"20","author":"Mo","year":"2022","journal-title":"J Transl Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00848-y","article-title":"Tissue-specific macrophages: how they develop and choreograph tissue biology","volume":"23","author":"Mass","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004794","article-title":"TIGIT blockade repolarizes AML-associated TIGIT(+) M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis","volume":"10","author":"Brauneck","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf8522","article-title":"M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism","volume":"9","author":"Weinhauser","year":"2023","journal-title":"Sci Adv"},{"key":"B53","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41419-023-05822-z","article-title":"Sox13 and M2-like leukemia-associated macrophages contribute to endogenous IL-34 caused accelerated progression of acute myeloid leukemia","volume":"14","author":"Zhang","year":"2023","journal-title":"Cell Death Dis"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-021-04734-2","article-title":"Phase 1 study of anti-CD47 monoclonal antibody CC-90002 in patients with relapsed\/refractory acute myeloid leukemia and high-risk myelodysplastic syndromes","volume":"101","author":"Zeidan","year":"2022","journal-title":"Ann Hematol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-23-0202","article-title":"Recent advances in immune-based therapies for acute myeloid leukemia","volume":"5","author":"Restelli","year":"2024","journal-title":"Blood Cancer Discov"},{"key":"B56","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-024-01777-5","article-title":"RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct Target Ther"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1739959\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T06:30:07Z","timestamp":1770100207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1739959\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":56,"alternative-id":["10.3389\/fimmu.2026.1739959"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1739959","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"article-number":"1739959"}}